
Managing low-level HIV viraemia in antiretroviral therapy: a …
HIV-1 management has advanced significantly with antiretroviral therapy (ART), yet challenges persist, including low-level HIV-1 viraemia (LLV). LLV presents a complex scenario, with varied definitions in the literature, reflecting uncertainties in its clinical interpretation.
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal ...
Our objective was to characterize longitudinal patterns of viraemia and factors associated with viral suppression in people with HIV and low-level viraemia (LLV) during antiretroviral therapy (ART). We included people with HIV in the EuResist Integrated Database with LLV following ART initiation after 2005.
Managing low-level HIV viraemia in antiretroviral therapy: a …
2024年10月17日 · Objective: HIV-1 management has advanced significantly with antiretroviral therapy (ART), yet challenges persist, including low-level HIV-1 viraemia (LLV). LLV presents a complex scenario, with varied definitions in the literature, reflecting uncertainties in …
How relevant is the HIV low level viremia and how is its …
Background: It is still unclear what might be the best management of people living with HIV (PLWHIV) with low level viremia (LLV) despite being on antiretroviral treatment (ART). Objectives: Aim of our study is to describe the clinical management of PLWHIV with LLV followed in a …
Characteristics of drug resistance mutations in ART ... - Nature
2024年5月9日 · Plasma human immunodeficiency virus-1 (HIV-1) RNA level is an important marker for clinical diagnosis of HIV infection and efficacy evaluation of...
The prevalence of low-level viraemia and its association with ...
We found the global prevalence of LLV was 13.81%, with its occurrence associated with high baseline VL, AIDS-defining illness, and PI-based regimens at the initiation of ART. Moreover, LLV was strongly associated with an increased risk of VF and all-cause mortality.
Clinical significance and management of low‐level HIV viremia in …
2023年11月22日 · Antiretroviral therapy (ART) is the cornerstone of HIV-1 treatment. ART aims to achieve virologic suppression (VS) in people living with HIV (PLWH). Adequate VS could prevent the development of resistance mutations, reduce HIV transmission and improve clinical outcomes [2].
Low-level viremia episodes appear to affect the provirus ... - PubMed
2024年5月22日 · Low-level viremia (LLV) ranging from 50 to 1,000 copies/ml is common in most HIV-1-infected patients receiving antiretroviral therapy (ART). However, the source of LLV and the impact of LLV on the HIV-1 reservoir during ART remain uncertain.
人类免疫缺陷病毒感染/艾滋病患者抗反转录病毒治疗后的低病毒血 …
本研究调查了5 394例hiv-1感染/aids患者接受art超过1年后发生llv的比例,以及llv对其后期抗病毒治疗应答的影响,以探讨llv的临床意义。 试读结束, 个人账户登录 后阅读更多内容。
(PDF) Managing low-level HIV viraemia in antiretroviral therapy: a ...
2024年9月17日 · Objective HIV-1 management has advanced significantly with antiretroviral therapy (ART), yet challenges persist, including low-level HIV-1 viraemia (LLV). LLV presents a complex scenario,...
- 某些结果已被删除